The Potency of Refined Mouse Models: Implications for Clinical Trials

E-ISSN： 1875-6301|6|1|62-80

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.6, Iss.1, 2010-02, pp. : 62-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Biological Implications of the Milan Breast Conservation Trials

By Vaidya J.S. Baum M.

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1143-1144

Elsevier

Access to resources Recommend Favorite

Mechanisms of radiation-induced skin injury and implications for future clinical trials

By Kim Jae Ho Kolozsvary Andrew J. J. Jenrow Kenneth A. Brown Stephen L.

International Journal of Radiation Biology, Vol. 89, Iss. 5, 2013-05 ,pp. : 311-318

Informa Healthcare

Access to resources Recommend Favorite

The U.S. Pediatric Cancer Clinical Trials Programmes: International Implications and the Way Forward

By Bleyer W.A.

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1439-1447

Elsevier

Access to resources Recommend Favorite

Carcinoembryonic Antigen (CEA)-Based Cancer Vaccines: Recent Patents and Antitumor Effects from Experimental Models to Clinical Trials

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 3, 2012-09 ,pp. : 265-296

Bentham Science Publishers

Access to resources Recommend Favorite

HIPEC: The Complexities of Clinical Trials

By Bartlett David

Annals of Surgical Oncology, Vol. 15, Iss. 5, 2008-05 ,pp. : 1277-1279

Springer Publishing Company

Access to resources Recommend Favorite